-- Preview Email Newsletter
| State Tipoffs Involving Delaware Newsletter for 2023-04-23 ( 7 items ) |
|
Avelo Adds New Destination at RDU (10)
MORRISVILLE, North Carolina, April 21 -- Raleigh-Durham International Airport issued the following news release:
Avelo Airlines inaugural flight arriving from New Haven, CT to Raleigh-Durham International Airport on May 26, 2022.
Nonstop Route to the Philadelphia Region Starts This Summer:
RDU's fastest-growing airline will add a new nonstop destination this summer in time for the airport's busiest travel season. Avelo Airlines will begin service to Wilmington, Delaware in June - their 12th r more PR
Avelo Airlines Announces 2nd Destination-Wilmington, DE - To/from Daytona Beach International Airport (10)
DAYTONA BEACH, Florida, April 21 -- The Daytona Beach International Airport issued the following news release:
Avelo Airlines is expanding service at Daytona Beach International Airport (DAB) with exclusive nonstop flights to Delaware's Wilmington Airport (ILG) - a convenient and easy alternative to Philadelphia International Airport (PHL). Avelo will be the only airline flying between Daytona Beach and The First State.
Wilmington Airport is conveniently located a short drive south of Philadel more PR
Del. A.G. Jennings: Overdose Review Commission Releases 2022 Annual Report (10)
DOVER, Delaware, April 18 (TNSres) -- Delaware Attorney General Kathy Jennings issued the following news release:
The Delaware Drug Overdose Fatality Review Commission (DOFRC) has released its second annual report to Governor John Carney and the General Assembly, announced Attorney General Kathy Jennings. The report examines a sample of 108 cases from fatal overdoses that occurred in 2020, and includes data collected from death certificates, medical records, legal records, and treatment history more PR
Del. Gov. Carney Releases Statement on House Bill 1 and House Bill 2 (10)
DOVER, Delaware, April 22 -- Gov. John C. Carney, D-Delaware, issued the following statement on April 21, 2023:
* * *
"In the coming days, I will allow House Bill 1 and House Bill 2 to be enacted into Delaware law without my signature. These two pieces of legislation remove all state-level civil and criminal penalties from simple marijuana possession and create a highly regulated industry to conduct recreational marijuana sales in Delaware. As I've consistently said, I believe the legalization more PR
DuPont Schedules First Quarter 2023 Earnings Conference Call (10)
WILMINGTON, Delaware, April 19 (TNSres) -- DuPont issued the following news release:
DuPont (NYSE: DD) will release its first quarter 2023 financial results at 6:00 a.m. ET on Tuesday, May 2, 2023. In addition, the company will host a conference call at 8:00 a.m. ET that day.
Ed Breen, Executive Chairman and Chief Executive Officer, and Lori Koch, Chief Financial Officer, will review financial and operating performance for the period.
The event will be webcast live and can be accessed on DuPo more PR
DuPont to Source Renewable Energy Through Wind Energy Center in Texas (10)
WILMINGTON, Delaware, April 21 -- DuPont issued the following news release on April 20, 2023:
DuPont (NYSE: DD) today announced Appaloosa Run Wind Energy Center, a wind energy project resulting from a virtual power purchase agreement (VPPA) with a subsidiary of NextEra Energy Resources, LLC, is operational and generating clean, renewable energy.
The Appaloosa Run Wind Energy Center, located in Upton County, Texas, will generate 135 megawatts of new wind power capacity or approximately 528,000 more PR
IMFINZI-Based Treatment Before and After Surgery Reduced the Risk of Disease Recurrence, Progression Events or Death by 32% in Resectable Non-Small Cell Lung Cancer in the AEGEAN Phase III Trial (10)
WILMINGTON, Delaware, April 17 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release on April 16, 2023:
Positive results from the AEGEAN Phase III trial showed that treatment with AstraZeneca's IMFINZI(R) (durvalumab) in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery led to a statistically significant and clinically meaningful improvement in event-free survival (EFS) versus neoadjuvant chemotherapy alone follo more PR
|
